MARKET

BHC

BHC

Bausch Health Companies Inc
NYSE
5.17
+0.06
+1.17%
Closed 19:10 06/09 EDT
OPEN
5.17
PREV CLOSE
5.11
HIGH
5.26
LOW
5.09
VOLUME
1.81M
TURNOVER
--
52 WEEK HIGH
8.69
52 WEEK LOW
4.760
MARKET CAP
1.93B
P/E (TTM)
-1.5933
1D
5D
1M
3M
1Y
5Y
1D
Bausch Health signs letter of intent with pan-Canadian Pharmaceutical Alliance for public coverage of OKEDI schizophrenia drug
PUBT · 18h ago
Bausch Health Canada, pCPA sign LOI on public drug plan coverage for PrOKEDI schizophrenia treatment
PUBT · 18h ago
Bausch Health, Canada, Completes Negotiations With pan-Canadian Pharmaceutical Alliance Resulting In LOI For PrOKEDI 75mg And 100mg, Long-Acting Injectable Antipsychotic Agent For Schizophrenia Treatment
Benzinga · 20h ago
BAUSCH HEALTH, CANADA INC. AND THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE SIGN LETTER OF INTENT FOR PUBLIC DRUG PLAN COVERAGE OF (PR)OKEDI® (RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION) FOR THE TREATMENT OF SCHIZOPHRENIA
Reuters · 20h ago
Weekly Report: what happened at BHC last week (0601-0605)?
Weekly Report · 1d ago
UPDATE 2-Cooper Companies beats quarterly estimates on strong contact lenses demand
Reuters · 5d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Bausch Health Companies (BHC) and Healthequity (HQY)
TipRanks · 06/03 08:10
Bausch Health Companies Enters Oversold Territory (BHC)
NASDAQ · 06/02 20:29
More
About BHC
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.

Webull offers Bausch Health Companies Inc stock information, including NYSE: BHC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BHC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BHC stock methods without spending real money on the virtual paper trading platform.